Search Results 3321-3330 of 23878 for menopause

1. Highlights of Mayo Clinic research advancements in 2023

   Menopause-related symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, joint aches and cognitive difficulties damage the quality of ...

2. Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome - Mayo Clinic

   drug administration) in the opinion of the Investigator. 24. Females of childbearing potential (those who are not surgically sterilized or post-menopausal for ...

3. Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (COLT) - Mayo Clinic

   ... menopausal for at least 12 consecutive months with follicle-stimulating hormone (FSH >=40 IU/mL or 24 consecutive months if an FSH is not available, i.e. ...

4. A Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection - Mayo Clinic

   becoming post-menopausal unless permanently sterile) and fertile men (ie, all men after puberty unless permanently sterile by bilateral orchidectomy) agree ...

5. Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study - Mayo Clinic

   Participants must have been pre- or peri-menopausal at the time of breast cancer diagnosis by satisfying one of the following: had a menstrual period (by ...

6. Adenomyosis - Symptoms and causes - Mayo Clinic

   Doctors aren't sure what causes adenomyosis, but the disease usually resolves after menopause. For women who have severe discomfort from adenomyosis ...

7. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

   In addition, females \<55 years old must have a serum follicle stimulating hormone (FSH) level \>40 mIU/mL to confirm menopause. Note: Documentation may ...

8. AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH - Mayo Clinic

   Females on HRT and whose menopausal status is in doubt will be required to use the contraception methods in Appendix 20.3 if they wish to continue their HRT ...

9. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

   Women are considered post-menopausal and not of child bearing potential if they have had 12 months of natural (spontaneous) amenorrhea with an appropriate ...

10. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

    ... menopause (i.e., no menstrual bleeding for more than 12 months in women aged 45 years or more), OR woman of child bearing potential who test negative for ...